These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12115)

  • 61. The effect of labetalol in the treatment of severe drug-resistant hypertension.
    Morgan T; Gillies A; Morgan G; Adam W
    Med J Aust; 1978 Apr; 1(7):393-6. PubMed ID: 672730
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
    Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
    Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
    [No Abstract]   [Full Text] [Related]  

  • 63. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
    Weber MA; Drayer JI; Kaufman CA
    J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of labetalol with other anti-hypertensive drugs.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):41S-47S. PubMed ID: 6124265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of hypertension in the elderly with labetalol.
    Eisalo A; Virta P
    Acta Med Scand Suppl; 1982; 665():129-33. PubMed ID: 6961759
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Labetalol in hypertension.
    Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
    [No Abstract]   [Full Text] [Related]  

  • 67. Labetalol: an alpha- and beta-blocker.
    Conner CS
    Drug Intell Clin Pharm; 1983; 17(7-8):543-4. PubMed ID: 6135593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension.
    Prichard BN; Thompson FO; Boakes AJ; Joekes AM
    Clin Sci Mol Med Suppl; 1975 Jun; 2():97s-100s. PubMed ID: 802650
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
    Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF; White DA
    S Afr Med J; 1983 Jan; 63(3):67-71. PubMed ID: 6849167
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
    [No Abstract]   [Full Text] [Related]  

  • 73. Giant, dopamine secreting thoracoabdominal neuroblastoma in a 2-year-old: rapid preoperative blockade with labetalol.
    Pappas L; Shamberger RC; Seefelder C
    J Pediatr Hematol Oncol; 2010 Mar; 32(2):163-6. PubMed ID: 20147848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP; Bloomfield SS
    Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of labetalol in moderate to severe hypertension.
    Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Labetalol and propranolol in mild hypertensives: comparison of blood pressure and plasma volume effects.
    Hunyor SN; Bauer GE; Ross M; Larkin H
    Aust N Z J Med; 1980 Apr; 10(2):162-6. PubMed ID: 6930206
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antihypertensive effectiveness of intravenous labetalol in accelerated hypertension.
    Smith WB; Clifton GG; O'Neill WM; Wallin JD
    Hypertension; 1983; 5(4):579-83. PubMed ID: 6862581
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension.
    Doyle AE
    Hypertension; 1983; 5(4 Pt 2):II103-8. PubMed ID: 6134671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.